Loading…
Based on limited metadata, this warning letter was issued to xsteroids.com, an online vendor, regarding unapproved drug products on August 31, 2020. While the specific violations cannot be determined without access to the full letter text, the subject line and company name suggest the FDA took action regarding controlled or unapproved steroid medications being distributed online. The warning falls under FDA's drug product enforcement authority, though the specific issuing office is not identified in the available metadata.